+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Breast Cancer Diagnostics Market Research Report by Technique, Cancer Type, Component, Diagnostic Type, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 257 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5206469
UP TO OFF until Dec 31st 2022
The Global Breast Cancer Diagnostics Market size was estimated at USD 5,685.81 million in 2021, USD 6,129.25 million in 2022, and is projected to grow at a CAGR 7.97% to reach USD 9,010.75 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Breast Cancer Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technique, the market was studied across Imaging, Molecular Testing, and Tissue Biopsy Tests. The Imaging is further studied across Analog Mammography, Breast Ultrasound System, Digital Mammography, Mammography, MRI Scan, and PET/CT Scan.
  • Based on Cancer Type, the market was studied across BRCA Breast Cancer, EGFR Mutation Test Breast Cancer, ER & PR Breast Cancer, and HER 2 Breast Cancer.
  • Based on Component, the market was studied across Consumables and Instruments. The Consumables is further studied across Antibodies, Kits & Reagents, and Probes. The Instruments is further studied across Biopsy Instruments, Imaging Instruments, and Pathology-based Instruments.
  • Based on Diagnostic Type, the market was studied across Ionizing Breast Imaging Technologies and Non-ionizing Imaging Technologies.
  • Based on End-user, the market was studied across Diagnostic Laboratories, Hospitals & Ambulatory Surgery Center, and Research & Academic Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Breast Cancer Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Breast Cancer Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Breast Cancer Diagnostics Market, including Abbott Laboratories, Agilent Technologies, Inc., Ascenda BioSciences LLC, AstraZeneca, PLC, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, Biocept, Inc., BioNTech SE, C.R. Bard, Inc., Danaher Corporation, Epigenomics Inc, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, GE Healthcare, Genomic Health, Hologic Inc., Illumina, Inc., Koninklijke Philips N.V., Leica Biosystems, Myriad Genetics, Inc., NanoString Technologies, Inc, Paragon Biosciences LLC, Questex LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Todos Medical, and Toshiba Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Breast Cancer Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Breast Cancer Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Breast Cancer Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Breast Cancer Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Breast Cancer Diagnostics Market?
6. What is the market share of the leading vendors in the Global Breast Cancer Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Breast Cancer Diagnostics Market?
Frequently Asked Questions about the Global Breast Cancer Diagnostics Market

What is the estimated value of the Global Breast Cancer Diagnostics Market?

The Global Breast Cancer Diagnostics Market was estimated to be valued at $5685.81 Million in 2021.

What is the growth rate of the Global Breast Cancer Diagnostics Market?

The growth rate of the Global Breast Cancer Diagnostics Market is 7.9%, with an estimated value of $9010.75 Million by 2027.

What is the forecasted size of the Global Breast Cancer Diagnostics Market?

The Global Breast Cancer Diagnostics Market is estimated to be worth $9010.75 Million by 2027.

Who are the key companies in the Global Breast Cancer Diagnostics Market?

Key companies in the Global Breast Cancer Diagnostics Market include Abbott Laboratories, Agilent Technologies, Inc., Ascenda BioSciences LLC, AstraZeneca, PLC, Becton, Dickinson, and Company, Bio, Rad Laboratories, Inc, Biocept, Inc. and C.R. Bard, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of breast cancer
5.1.1.2. Favourable reimbursement framework for breast cancer diagnosis
5.1.1.3. Growing number of breast cancer screening programs
5.1.2. Restraints
5.1.2.1. Dearth of the skilled and trained professionals
5.1.3. Opportunities
5.1.3.1. Technological advancements such as introduction of hybrid imaging technique
5.1.3.2. Focus on development of effective diagnostic
5.1.4. Challenges
5.1.4.1. Ignorance of the prediagnostic symptoms
5.2. Cumulative Impact of COVID-19
6. Breast Cancer Diagnostics Market, by Technique
6.1. Introduction
6.2. Imaging
6.2.1. Analog Mammography
6.2.2. Breast Ultrasound System
6.2.3. Digital Mammography
6.2.4. Mammography
6.2.5. MRI Scan
6.2.6. PET/CT Scan
6.3. Molecular Testing
6.4. Tissue Biopsy Tests
7. Breast Cancer Diagnostics Market, by Cancer Type
7.1. Introduction
7.2. BRCA Breast Cancer
7.3. EGFR Mutation Test Breast Cancer
7.4. ER & PR Breast Cancer
7.5. HER 2 Breast Cancer
8. Breast Cancer Diagnostics Market, by Component
8.1. Introduction
8.2. Consumables
8.2.1. Antibodies
8.2.2. Kits & Reagents
8.2.3. Probes
8.3. Instruments
8.3.1. Biopsy Instruments
8.3.2. Imaging Instruments
8.3.3. Pathology-based Instruments
9. Breast Cancer Diagnostics Market, by Diagnostic Type
9.1. Introduction
9.2. Ionizing Breast Imaging Technologies
9.3. Non-ionizing Imaging Technologies
10. Breast Cancer Diagnostics Market, by End-user
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals & Ambulatory Surgery Center
10.4. Research & Academic Institutes
11. Americas Breast Cancer Diagnostics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Breast Cancer Diagnostics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
13. Europe, Middle East & Africa Breast Cancer Diagnostics Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories
15.2. Agilent Technologies, Inc.
15.3. Ascenda BioSciences LLC
15.4. AstraZeneca, PLC
15.5. Becton, Dickinson, and Company
15.6. Bio-Rad Laboratories, Inc
15.7. Biocept, Inc.
15.8. BioNTech SE
15.9. C.R. Bard, Inc.
15.10. Danaher Corporation
15.11. Epigenomics Inc
15.12. F. Hoffmann-La Roche Ltd
15.13. FUJIFILM Holdings Corporation
15.14. GE Healthcare
15.15. Genomic Health
15.16. Hologic Inc.
15.17. Illumina, Inc.
15.18. Koninklijke Philips N.V.
15.19. Leica Biosystems
15.20. Myriad Genetics, Inc.
15.21. NanoString Technologies, Inc
15.22. Paragon Biosciences LLC
15.23. Questex LLC
15.24. Siemens Healthineers AG
15.25. Thermo Fisher Scientific Inc.
15.26. Todos Medical
15.27. Toshiba Corporation
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2027
FIGURE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2021 VS 2027 (%)
FIGURE 30. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2027
FIGURE 32. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2021 VS 2027 (%)
FIGURE 41. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2021 VS 2027 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2027
FIGURE 43. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 52. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 53. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 54. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 55. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 56. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 57. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 58. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 59. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2021 VS 2027 (%)
FIGURE 60. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2027
FIGURE 62. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2019-2027 (USD MILLION)
FIGURE 63. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 64. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, 2019-2027 (USD MILLION)
FIGURE 65. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 66. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 67. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2027
FIGURE 69. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 70. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 71. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, 2019-2027 (USD MILLION)
FIGURE 72. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 73. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 74. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 75. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 77. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 79. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 85. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 86. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2027
FIGURE 87. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 89. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 90. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 91. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 94. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 95. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 96. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 97. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 98. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. TAIWAN BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. THAILAND BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 104. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 105. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 106. FRANCE BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 107. GERMANY BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 108. ITALY BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 109. NETHERLANDS BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 110. QATAR BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 111. RUSSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 112. SAUDI ARABIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 113. SOUTH AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 114. SPAIN BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 115. UNITED ARAB EMIRATES BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 116. UNITED KINGDOM BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 117. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 118. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 119. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BREAST CANCER DIAGNOSTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 73. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 84. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2019-2027 (USD MILLION)
TABLE 89. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY STATE, 2019-2027 (USD MILLION)
TABLE 91. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 94. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 96. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 99. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 100. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 101. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 104. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 105. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 106. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 109. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 110. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 111. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 113. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 114. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 115. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 117. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 120. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 122. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 124. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 125. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 126. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 127. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 128. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 130. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2019-2027 (USD MILLION)
TABLE 131. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 132. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY STATE, 2019-2027 (USD MILLION)
TABLE 133. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 135. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 136. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 137. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 138. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 140. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 142. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 143. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 144. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 145. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 146. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 147. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 149. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 150. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 151. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 152. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 153. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 155. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 156. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 157. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 158. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 159. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 160. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 161. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 162. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 163. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 164. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 165. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 167. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 168. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 169. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 170. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 171. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 172. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 173. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 174. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 175. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 176. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 177. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 178. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 180. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 181. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 182. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 183. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 184. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 185. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 186. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 187. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 188. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 189. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 190. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 191. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 192. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 193. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 194. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 195. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 196. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 197. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 198. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 199. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 200. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 201. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 202. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 203. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 204. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 205. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 206. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 207. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 208. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 209. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 210. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 211. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 212. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 213. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 214. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 215. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 216. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 217. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 218. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 219. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 220. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 221. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 222. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 223. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 224. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 225. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 226. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 227. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 228. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 229. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 230. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 231. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 232. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 233. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 234. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 235. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 236. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 237. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 238. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 239. TAIWAN BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 240. TAIWAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 241. TAIWAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 242. TAIWAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 243. TAIWAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 244. TAIWAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 245. THAILAND BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 246. THAILAND BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 247. THAILAND BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 248. THAILAND BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 249. THAILAND BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 250. THAILAND BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 258. FRANCE BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 259. FRANCE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 260. FRANCE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 261. FRANCE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 262. FRANCE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 263. FRANCE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 264. GERMANY BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 265. GERMANY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 266. GERMANY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 267. GERMANY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 268. GERMANY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 269. GERMANY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 270. ITALY BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 271. ITALY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 272. ITALY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 273. ITALY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 274. ITALY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 275. ITALY BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 276. NETHERLANDS BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 277. NETHERLANDS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 278. NETHERLANDS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 279. NETHERLANDS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 280. NETHERLANDS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 281. NETHERLANDS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 282. QATAR BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 283. QATAR BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 284. QATAR BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 285. QATAR BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 286. QATAR BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 287. QATAR BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 288. RUSSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 289. RUSSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 290. RUSSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 291. RUSSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 292. RUSSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 293. RUSSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 294. SAUDI ARABIA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 295. SAUDI ARABIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 296. SAUDI ARABIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 297. SAUDI ARABIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 298. SAUDI ARABIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MILLION)
TABLE 299. SAUDI ARABIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 300. SOUTH AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 301. SOUTH AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 302. SOUTH AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2019-2027 (USD MILLION)
TABLE 303. SOUTH AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 304. SOUTH AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2019-2027 (USD MI

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ascenda BioSciences LLC
  • AstraZeneca, PLC
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc
  • Biocept, Inc.
  • BioNTech SE
  • C.R. Bard, Inc.
  • Danaher Corporation
  • Epigenomics Inc
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Genomic Health
  • Hologic Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Leica Biosystems
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc
  • Paragon Biosciences LLC
  • Questex LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Todos Medical
  • Toshiba Corporation

Methodology

Loading
LOADING...